Modulation of peristalsis in the guinea-pig isolated small intestine by exogenous and endogenous opioids
- PMID: 1356564
- PMCID: PMC1907666
- DOI: 10.1111/j.1476-5381.1992.tb14448.x
Modulation of peristalsis in the guinea-pig isolated small intestine by exogenous and endogenous opioids
Abstract
1. A recording method was developed to measure physiological parameters of the preparatory and emptying phases of peristalsis in vitro. This method enabled measurement of: the compliance of the intestinal wall during the preparatory phase (a reflection of the resistance of the wall to distension); longitudinal muscle contraction during the preparatory phase; the threshold volume required to trigger the emptying phase; the maximal ejection pressure and the average power generated during the emptying phase, which reflects the rate at which the intestine performs work. Modulation of these parameters by exogenous and endogenous opioids acting at mu, kappa and delta opioid receptors was investigated. 2. The compliance of the intestinal wall during the preparatory phase was reduced by the mu opioid receptor agonist, [D-Ala2, N-methyl-Phe4, Gly5-ol] enkephalin (DAMGO) but not by the kappa agonist, dynorphin, or the delta agonist, [D-penicillamine2, D-penicillamine5] enkephalin (DPDPE). Reflex contraction of the longitudinal muscle during the preparatory phase was inhibited by DAMGO, dynorphin and DPDPE. The threshold volume required to trigger the emptying phase of peristalsis was increased by DAMGO, dynorphin and DPDPE. 3. The maximal ejection pressure generated during the emptying phase was reduced by dynorphin and DPDPE, but not by DAMGO. The average power generated by the intestine when emptying was not altered by any of the agonists. 4. Electrically stimulated contractions of longitudinal muscle in strips of longitudinal muscle-myenteric plexus were not inhibited by DPDPE. Similarly, DPDPE did not significantly inhibit electrically induced contraction of circular muscle in strips of circular muscle-myenteric plexus.5. Each of the agonist effects on peristaltic parameters was antagonized by the appropriate antagonist:D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) (mu), norbinaltorphimine (nor-BNI) (kappa), naltrindole(delta).6. It is concluded that mu and kappa agonists act primarily on excitatory circular and longitudinal muscle motor neurones. The delta agonist probably acts on enteric neurones presynaptic to excitatory circular and longitudinal muscle motor neurones.7. Antagonists for mu, delta and kappa receptors did not affect any parameters of peristalsis when the intestine emptied against a low resistance. However, when emptying against a high outflow resistance, the average power generated by the intestine was increased by the kappa antagonist, nor-BNI, but not by CTOP or naltrindole.8. It is concluded that endogenous opioids appear to have little role in peristalsis when the intestine is working against a low outflow resistance. However endogenous opioids, acting primarily at kappa receptors,provide a braking mechanism by inhibiting the emptying phase of peristalsis in conditions in which the intestine empties against a higher resistance.
Similar articles
-
Role of kappa opioid receptors in modulating cholinergic twitches in the circular muscle of guinea-pig colon.Br J Pharmacol. 1996 Nov;119(5):985-9. doi: 10.1111/j.1476-5381.1996.tb15768.x. Br J Pharmacol. 1996. PMID: 8922749 Free PMC article.
-
Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.J Pharmacol Exp Ther. 1989 May;249(2):462-9. J Pharmacol Exp Ther. 1989. PMID: 2566676
-
Role of central mu, delta-1, and kappa-1 opioid receptors in opioid-induced muscle rigidity in the rat.Anesthesiology. 1996 Sep;85(3):574-83. doi: 10.1097/00000542-199609000-00017. Anesthesiology. 1996. PMID: 8853088
-
Mechanisms of the analgesic actions of opiates and opioids.Br Med Bull. 1991 Jul;47(3):690-702. doi: 10.1093/oxfordjournals.bmb.a072501. Br Med Bull. 1991. PMID: 1665377 Review.
-
Role of opioid ligands in the irritable bowel syndrome.Can J Gastroenterol. 1999 Mar;13 Suppl A:71A-75A. doi: 10.1155/1999/598659. Can J Gastroenterol. 1999. PMID: 10202212 Review.
Cited by
-
Characterization of putative interneurons in the myenteric plexus of human colon.Neurogastroenterol Motil. 2021 Jan;33(1):e13964. doi: 10.1111/nmo.13964. Epub 2020 Aug 24. Neurogastroenterol Motil. 2021. PMID: 32839997 Free PMC article.
-
Novel insights into mechanisms of inhibition of colonic motility by loperamide.Front Neurosci. 2024 Aug 29;18:1424936. doi: 10.3389/fnins.2024.1424936. eCollection 2024. Front Neurosci. 2024. PMID: 39268036 Free PMC article.
-
Role of kappa opioid receptors in modulating cholinergic twitches in the circular muscle of guinea-pig colon.Br J Pharmacol. 1996 Nov;119(5):985-9. doi: 10.1111/j.1476-5381.1996.tb15768.x. Br J Pharmacol. 1996. PMID: 8922749 Free PMC article.
-
Neuromodulatory processes of the brain-gut axis.Neuromodulation. 2008 Oct 1;11(4):249-259. doi: 10.1111/j.1525-1403.2008.00172.x. Neuromodulation. 2008. PMID: 19844605 Free PMC article.
-
Modulation of peristalsis by cannabinoid CB(1) ligands in the isolated guinea-pig ileum.Br J Pharmacol. 2000 Mar;129(5):984-90. doi: 10.1038/sj.bjp.0703116. Br J Pharmacol. 2000. PMID: 10696099 Free PMC article.
References
-
- Science. 1977 Jan 28;195(4276):419-20 - PubMed
-
- Naunyn Schmiedebergs Arch Pharmacol. 1987 Oct;336(4):419-24 - PubMed
-
- Naunyn Schmiedebergs Arch Pharmacol. 1979 Jul;307(3):257-64 - PubMed
-
- Br J Pharmacol. 1977 Dec;61(4):639-47 - PubMed
-
- Naunyn Schmiedebergs Arch Pharmacol. 1988 Oct;338(4):397-400 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials